Abstract

ABSTRACT Accumulating evidence points to Akkermansia muciniphila as a novel candidate to prevent or treat obesity-related metabolic disorders. We recently observed, in mice and in humans, that pasteurization of A. muciniphila increases its beneficial effects on metabolism. However, it is currently unknown if the observed beneficial effects on body weight and fat mass gain are due to specific changes in energy expenditure. Therefore, we investigated the effects of pasteurized A. muciniphila on whole-body energy metabolism during high-fat diet feeding by using metabolic chambers. We confirmed that daily oral administration of pasteurized A. muciniphila alleviated diet-induced obesity and decreased food energy efficiency. We found that this effect was associated with an increase in energy expenditure and spontaneous physical activity. Strikingly, we discovered that energy expenditure was enhanced independently from changes in markers of thermogenesis or beiging of the white adipose tissue. However, we found in brown and white adipose tissues that perilipin2, a factor associated with lipid droplet and known to be altered in obesity, was decreased in expression by pasteurized A. muciniphila. Finally, we observed that treatment with pasteurized A. muciniphila increased energy excretion in the feces. Interestingly, we demonstrated that this effect was not due to the modulation of intestinal lipid absorption or chylomicron synthesis but likely involved a reduction of carbohydrates absorption and enhanced intestinal epithelial turnover. In conclusion, this study further dissects the mechanisms by which pasteurized A. muciniphila reduces body weight and fat mass gain. These data also further support the impact of targeting the gut microbiota by using specific bacteria to control whole-body energy metabolism.

Highlights

  • Obesity and its ensuing metabolic disorders, including insulin resistance and cardiometabolic complications, represent a growing epidemic and economic burdens for public health authorities.[1,2] it is currently largely accepted that the gut microbiota can influence whole-body metabolism by affecting energy balance.[3]

  • At the end of the experiment, we found that the different adipose depots (SAT: subcutaneous; EAT: epididymal; VAT: visceral) were significantly smaller in the treated group, except for the brown adipose tissue (BAT), which remained similar between the three groups (Figure 1e)

  • By using metabolic chambers and indirect calorimetry, we found that the phenotype could be explained by several mechanisms including an enhanced energy expenditure and physical activity and an increased fecal energy excretion in the pasteurized A. muciniphila treated mice

Read more

Summary

Introduction

Obesity and its ensuing metabolic disorders, including insulin resistance and cardiometabolic complications, represent a growing epidemic and economic burdens for public health authorities.[1,2] it is currently largely accepted that the gut microbiota can influence whole-body metabolism by affecting energy balance.[3]. The beneficial effects of the bacteria on cardiometabolic features were thereafter supported by others using various pathological murine models.[17,18,19,20,21,22]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call